Latest News about BMY
Recent news which mentions BMY
'Fast Money Halftime Report' Picks For August 19
August 19, 2021
From Benzinga
3 Top Healthcare Stocks to Buy for August
August 19, 2021
From Motley Fool
From Motley Fool
Tags
AON
NYSE:BRK/B,NYSE:KR,NYSE:AON,NASDAQ:AAPL,NYSE:GM,NYSE:MRK,NYSE:ABBV,NYSE:BMY,NASDAQ:BIIB
Market News
From InvestorPlace
From Benzinga
5 Stocks Insiders Are Selling
August 17, 2021
From Benzinga
From Motley Fool
From Benzinga
Apple, GM, Kroger, AbbVie, Merck, Bristol Myers Squibb, Biogen — How Warren Buffett's Berkshire Adjusted Its Portfolio In Q2
August 17, 2021
From Benzinga
From Benzinga
4 Pharma Stocks You Can Buy and Hold for 20 Years
August 15, 2021
From Motley Fool
CytoSorbents' Antithrombotic Removal System Scores Second FDA Breakthrough Device Tag
August 12, 2021
From Benzinga
3 Best Biotech Stocks To Buy for Upcoming Catalysts
August 12, 2021
From InvestorPlace
From Benzinga
Why Agenus Fell by Over 4% on Monday
August 09, 2021
From Motley Fool
Here Are the 12 Best Dividend Stocks I Own Right Now
August 08, 2021
From Motley Fool
Is the PD-(L)1 Party Over After Incyte's FDA Rejection?
August 07, 2021
From Motley Fool
4 Perfect Dividend Stocks That'll Help You Crush Inflation
August 07, 2021
From Motley Fool
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
August 06, 2021
From Benzinga
From Benzinga
4 Stocks Insiders Are Selling
August 04, 2021
From Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
August 04, 2021
From Benzinga
'Fast Money Halftime Report' Picks For August 3
August 03, 2021
From Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
August 03, 2021
From Benzinga
AstraZeneca' Saphnelo Wins FDA Nod For Systemic Lupus Erythematosus, Marking New Treatment Approval In 10 Years
August 02, 2021
From Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
From Benzinga
Biogen: Does Aduhelm Make it the Next Dendreon?
July 30, 2021
From InvestorPlace
Bristol Myers' Opdivo Scores European Approval As Adjuvant Treatment For Gastric Cancer
July 30, 2021
Tickers
BMY
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.